Abstract
Despite research comparing adherence/persistence among long-acting injectables (LAIs) and oral antipsychotics (OAPs), a systematic synthesis of the available evidence is lacking. This study systematically reviewed real world evidence comparing LAIs and OAPs adherence/persistence among patients with schizophrenia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
